FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns composition for preventing HIV transmission including polyclonal antibodies or fragments thereof, capable to bind with protein of human immunodeficiency virus (HIV) viral envelope (Env) or its fragment, wherein polyclonal antibodies or fragments thereof (i) are capable to bind with Env protein from HIV heterologous strain and (ii) are present in hyperimmune animal milk or obtained from hyperimmune animal milk, are present in hyperimmune colostrum animal or obtained from hyperimmune animal colostrum or are present in bird egg or obtained from bird eggs. Group of inventions also concerns using said composition for producing drugs for preventing HIV transmission; method of preventing HIV transmission, including topical introduction of said composition.
EFFECT: group of inventions provides prevention of HIV transmission.
45 cl, 12 ex, 6 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW Tat-COMPLEXES AND VACCINES CONTAINING THEM | 2005 |
|
RU2432356C2 |
| pBMC-gp140(A)-hum EXPRESSION PLASMA DNA | 2006 |
|
RU2346044C2 |
| ROTAVIRAL PARTICLES WITH CHIMERIC SURFACE PROTEINS | 2014 |
|
RU2698049C2 |
| RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
| IMMUNOPROPHYLACTIC VACCINE AGAINST HIV BASED ON HIV-SPECIFIC ANTIBODIES | 2008 |
|
RU2505604C2 |
| MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
| COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
| RECOMBINANT CHIMERICAL nTBI POLYPEPTIDE-IMMUNOGEN WITH ABILITY TO INDUCE NEUTRALIZING ANTIBODIES TO TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS AND INTENDED FOR USE AS COMPONENT OF VACCINE AGAINST HIV-1 | 2016 |
|
RU2642258C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HIV DISEASE IN HUMANS | 2012 |
|
RU2609769C2 |
| TREATMENT AND FUNCTIONAL CURE OF HIV-INFECTION WITH MONOCLONAL ANTIBODIES TO CD4 MEDIATING COMPETITIVE INHIBITION OF HIV ENTRY | 2014 |
|
RU2762315C2 |
